Previous Article | Next Article ![]()
Infection and Immunity, November 1998, p. 5357-5363, Vol. 66, No. 11
Section of
Gastroenterology1 and
Maxwell Finland
Laboratory for Infectious Diseases,2 Boston
Medical Center, Boston University School of Medicine, Boston,
Massachusetts 02118, and
Gastroenterology Division, Beth Israel
Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
022153
Received 8 January 1998/Returned for modification 27 March
1998/Accepted 5 August 1998
Helicobacter pylori gastritis is characterized by
leukocyte infiltration of the gastric mucosa. The aims of this study
were to determine whether H. pylori-derived factors
stimulate chemokine release from human monocytes and to ascertain
whether H. pylori lipopolysaccharide (LPS) may be
responsible for this effect. Human peripheral blood monocytes were
exposed to an H. pylori water extract (HPE) or to purified
H. pylori LPS. Levels of the chemokines interleukin-8
(IL-8), epithelial neutrophil-activating peptide 78 (ENA-78), and
monocyte chemotactic protein 1 (MCP-1) were measured by enzyme-linked
immunosorbent assay. The contribution of H. pylori LPS to
monocyte activation was determined by using the LPS antagonist Rhodobacter sphaeroides lipid A (RSLA) and a blocking
monoclonal antibody to CD14 (60bca). HPE increased monocyte secretion
of IL-8, ENA-78, and MCP-1. Heat treatment of HPE did not reduce its
ability to activate monocytes. Purified H. pylori LPS also stimulated monocyte chemokine production but was 1,000-fold less potent
than Salmonella minnesota lipid A. RSLA blocked H. pylori LPS-induced monocyte IL-8 release in a dose-dependent
fashion (maximal inhibition 82%, P < 0.001). RSLA
also inhibited HPE-induced IL-8 release (by 93%, P < 0.001). The anti-CD14 monoclonal antibody 60bca substantially inhibited
IL-8 release from HPE-stimulated monocytes (by 88%, P < 0.01), whereas the nonblocking anti-CD14 monoclonal antibody did
not. These experiments with potent and specific LPS inhibitors indicate
that the main monocyte-stimulating factor in HPE is LPS. H. pylori LPS, acting through CD14, stimulates human monocytes to
release the neutrophil-activating chemokines IL-8 and ENA-78 and the
monocyte-activating chemokine MCP-1. Despite its low relative potency,
H. pylori LPS may play an important role in the
pathogenesis of H. pylori gastritis.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Helicobacter pylori Lipopolysaccharide
Binds to CD14 and Stimulates Release of Interleukin-8, Epithelial
Neutrophil-Activating Peptide 78, and Monocyte Chemotactic
Protein 1 by Human Monocytes
*
Corresponding author. Mailing address: Dana 601, Gastroenterology, Beth Israel Deaconess Medical Center, 330 Brookline
Ave., Boston, MA 02215. Phone: (617) 667-1264. Fax: (617) 975-5071. E-mail: ciaran_kelly{at}bidmc.harvard.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|